ARAY — ACCURAY INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1138723 ·
Last close
$0.24
Market Cap
$28.83M
52W High
$2.10
52W Low
$0.22
ADV30
14,014,078
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 100,919,000 | 35,077,000 | 6,271,000 | -1,941,000 | — | 40,623,000 | 401,977,000 |
| Mar 2026 | 104,845,000 | 25,294,000 | -2,548,000 | -11,805,000 | 447,602,000 | 38,067,000 | 405,895,000 |
| Dec 2025 | 102,241,000 | 24,072,000 | -5,491,000 | -13,770,000 | 448,009,000 | 41,295,000 | 394,589,000 |
| Sep 2025 | 93,942,000 | 26,548,000 | -11,313,000 | -21,678,000 | 456,816,000 | 63,344,000 | 394,949,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,116,000
Investing CF
$-14,328,000
Financing CF
$-2,492,000
CapEx
$-14,328,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.37
As of
2026-08-30
Balance + Analyst (yfinance extras)
Retained Earnings
$-566,525,000
Inventory
$156,626,000
Receivables
$80,579,000
ST Investments
—
EBIT TTM
$-15,237,000
Pretax Income TTM
$-43,670,000
Interest Exp TTM
$28,433,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$401,947,008
EBITDA
$-3,528,000
Free Cash Flow
$10,565,625
Enterprise Value
$173,134,720
Total Cash
$40,623,000
Total Debt
$183,874,000
Shares Out
119,439,307
Trailing EPS
$-0.40
Book Value
$0.35
ROE
-80.1%
ROA
-1.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 401,947,000 | -10,270,000 | -49,194,000 | 443,676,000 | 401,977,000 | 41,699,000 | -6,981,000 |
| Jun 2025 | 458,505,000 | 7,839,000 | -1,591,000 | 470,239,000 | 389,070,000 | 81,169,000 | 2,860,000 |
| Jun 2024 | 446,551,000 | 504,000 | -15,545,000 | 468,627,000 | 423,543,000 | 45,084,000 | -11,904,000 |
| Jun 2023 | 447,605,000 | 2,382,000 | -9,280,000 | 479,214,000 | 425,555,000 | 53,659,000 | 15,539,000 |
TTM Snapshot
Revenues TTM
$428,571,000
NetIncome TTM
$-46,130,000
OpCashFlow TTM
—
Assets (Latest)
$447,602,000
Forward EPS
$-0.24
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $27.74M | $0.90 | — |
| PETV | PetVivo Holdings, Inc. | $27.66M | $0.73 | — |
| PAVM | PAVmed Inc. | $26.48M | $2.69 | — |
| HCIL | Hongchang International Co., Ltd | $26.30M | $0.05 | — |
| MLSS | MILESTONE SCIENTIFIC INC. | $32.62M | $0.36 | — |
News headlines (Yahoo Finance, 1h cache)
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
2026-10-06 20:10 · Yahoo
Accuray partners with Samsung NeuroLogica on CyberKnife imaging
2026-09-28 08:10 · Yahoo
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
2026-09-27 15:15 · Yahoo
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
2026-09-11 15:28 · Yahoo
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter
2026-08-28 21:31 · Yahoo
Accuray (ARAY) Q4 2026 Earnings Call Transcript
2026-08-26 21:30 · Yahoo
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic Transformation and Financial ...
2026-08-20 05:02 · Yahoo
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
2026-08-12 21:09 · Yahoo
Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity
2026-07-30 15:08 · Yahoo
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
2026-07-29 22:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.